Nobilis Therapeutics
PrivateLast Round
Grant
Sep 30, 2021
Total Funding Raised
$831,992
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nobilis Therapeutics is a biotechnology company that develops inhalation-based therapeutics using inert gas mixtures and portable delivery devices for the treatment of psychiatric and neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Mental Health, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nobilis Therapeutics Comparables
Compare Nobilis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GH Research | 77% | |
| Johnson & Johnson | 69% | |
| Biomind Labs Inc. | 69% | |
Nobilis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 30, 2021 | ||||
| Debt | Feb 15, 2018 | ||||
| Seed | Sep 7, 2016 |
Nobilis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 425% MoM, from 274 to 1.4K.
- Feb 15, 2018
$500K debt round completed.
Nobilis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nobilis Therapeutics's valuation, stock price, and market status.